Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Homaidan T. Alhomaidan, Naila Rasheed, Salem Almatrafi, Fahad H. Al-Rashdi & Zafar Rasheed. (2019) Bisphenol A modified DNA: A possible immunogenic stimulus for anti-DNA autoantibodies in systemic lupus erythematosus. Autoimmunity 52:7-8, pages 272-280.
Read now
Read now
Nicola Cirillo. (2012) Merging experimental data and in silico analysis: a systems-level approach to autoimmune disease and cancer. Expert Review of Clinical Immunology 8:4, pages 361-372.
Read now
Read now
Andras Perl. (2010) Systems biology of lupus: Mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. Autoimmunity 43:1, pages 32-47.
Read now
Read now
Andras Perl. (2010) Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity 43:1, pages 1-6.
Read now
Read now
Chang-Hee Suh & Hyoun-Ah Kim. (2008) Cytokines and their receptors as biomarkers of systemic lupus erythematosus. Expert Review of Molecular Diagnostics 8:2, pages 189-198.
Read now
Read now
Articles from other publishers (34)
Jisoo Oh, Keiji Oda, Marissa Brash, W. Lawrence Beeson, Joan Sabaté, Gary E Fraser & Synnove F Knutsen. (2023) Systemic Lupus Erythematosus and the Ratio of Omega-3 to Omega-6 Fatty Acids Consumption among Women in the Adventist Health Study-2. Lupus 32:14, pages 1637-1645.
Crossref
Crossref
Eugenia Enríquez-Merayo & Maria J. Cuadrado. (2023) Steroids in Lupus: Enemies or Allies. Journal of Clinical Medicine 12:11, pages 3639.
Crossref
Crossref
Tao You, Xiaoyin Lin, Chunhong Zhang, Weilun Wang & Meihong Lei. (2022) Correlation between serum β2-microglobulin level and systemic lupus erythematosus disease activity: A PRISMA-compliant meta-analysis. Medicine 101:39, pages e30594.
Crossref
Crossref
Vikas Kailashiya, Usha Singh & Jyotsna Kailashiya. (2022) CTLA4 gene polymorphism and its association with disease occurrence, clinical manifestations, serum markers and cytokine levels in SLE patients from North India. Indian Journal of Dermatology 67:3, pages 311.
Crossref
Crossref
Deepika Lal, Monika Thakur & Chhagan Bihari. (2020) Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis. Journal of Clinical and Experimental Hepatology 10:6, pages 574-580.
Crossref
Crossref
Vikas Kailashiya, Hanjabam Barun Sharma & Jyotsna Kailashiya. (2019)
Role of
CTLA4
A49G polymorphism in systemic lupus erythematosus and its geographical distribution
. Journal of Clinical Pathology 72:10, pages 659-662.
Crossref
Crossref
Miramir Aghdashi, Simak Salami & Ahmad Nezhadisalami. (2019) Evaluation of the serum β2 Microglobulin level in patients with systemic lupus erythematosus and its correlation with disease activity. BioMedicine 9:3, pages 16.
Crossref
Crossref
Saif Khan, Sajad A. Dar, Raju K. Mandal, Arshad Jawed, Mohd Wahid, Aditya K. Panda, Mohtashim Lohani, B. N. Mishra, Naseem Akhter & Shafiul Haque. (2018) Angiotensin-Converting Enzyme Gene I/D Polymorphism Is Associated With Systemic Lupus Erythematosus Susceptibility: An Updated Meta-Analysis and Trial Sequential Analysis. Frontiers in Physiology 9.
Crossref
Crossref
Weiguang Luo, Bin Zhou, Qizhi Luo, Huilong Fang, Xiaoxia Zuo & Yizhou Zou. (2017) Polymorphism of keratin 1 associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese population. PLOS ONE 12:10, pages e0186409.
Crossref
Crossref
Elaine V. LourençoAijing LiuGiuseppe Matarese & Antonio La Cava. (2016) Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation. Proceedings of the National Academy of Sciences 113:38, pages 10637-10642.
Crossref
Crossref
Gabriella Czifra, Balázs Tóth, Ildikó Kovács, Tamás Bíró, Zoltán Griger, Sándor Baráth, Tünde Tarr, Margit Zeher & Sándor Sipka. (2013) The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes of SLE patients. Rheumatology International 34:5, pages 717-720.
Crossref
Crossref
Alexandros P. Grammatikos, Vasileios C. Kyttaris, Katalin Kis-Toth, Lisa M. Fitzgerald, Amy Devlin, Michele D. Finnell & George C. Tsokos. (2014) A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus. Clinical Immunology 150:2, pages 192-200.
Crossref
Crossref
M-LF Hermansen, L Hummelshøj, D Lundsgaard, L Hornum, P Keller, J Fleckner, B Fox, LK Poulsen & S Jacobsen. (2012) Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Lupus 21:10, pages 1098-1104.
Crossref
Crossref
Thomas J. Covey, Janet L. Shucard, David W. Shucard, Shane Stegen & Ralph H.B. Benedict. (2012) Comparison of Neuropsychological Impairment and Vocational Outcomes in Systemic Lupus Erythematosus and Multiple Sclerosis Patients. Journal of the International Neuropsychological Society 18:03, pages 530-540.
Crossref
Crossref
Joseph M. Ahearn, Chau-Ching Liu, Amy H. Kao & Susan Manzi. (2012) Biomarkers for systemic lupus erythematosus. Translational Research 159:4, pages 326-342.
Crossref
Crossref
Andras Perl. (2012) Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE. Clinical Immunology 142:3, pages 219-222.
Crossref
Crossref
Z. Griger, B. I. Tóth, S. Baráth, Á. Gyetvai, I. Kovács, T. Tarr, T. Bíró, M. Zeher & S. Sipka. (2012) Different Effects of Bortezomib on the Expressions of Various Protein Kinase C Isoenzymes in T Cells of Patients with Systemic Lupus Erythematosus and in Jurkat Cells. Scandinavian Journal of Immunology 75:2, pages 243-248.
Crossref
Crossref
Erika Zilahi, Tünde Tarr, Gábor Papp, Zoltán Griger, Sándor Sipka & Margit Zeher. (2012) Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. Immunology Letters 141:2, pages 165-168.
Crossref
Crossref
Ahmad Taha Khalaf, Ji-Quan Song, Ting-Ting Gao, Xiang-Ping Yu & Tie-Chi Lei. (2011)
CTLA-4
Gene Polymorphism and the Risk of Systemic Lupus Erythematosus in the Chinese Population
. Journal of Biomedicine and Biotechnology 2011, pages 1-6.
Crossref
Crossref
Boglarka Brugos, Emese Kiss, Csaba Dul, Wolfgang Gubisch, Gyula Szegedi, Sandor Sipka & Margit Zeher. (2010) Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease. Human Immunology 71:9, pages 874-877.
Crossref
Crossref
Jufeng Zhang, Jingui Deng, Chao Zhang, Yanxin Lu, Li Liu, Qi Wu, Yong Shao, Jie Zhang, Hong Yang, Bo Yu & Jun Wan. (2010) Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population. Clinica Chimica Acta 411:11-12, pages 878-881.
Crossref
Crossref
Helga Kristjansdottir, Kristjan Steinsson, Iva Gunnarsson, Gerdur Gröndal, Kristjan Erlendsson & Marta E. Alarcón‐Riquelme. (2010) Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD‐1.3A genotype in patients with systemic lupus erythematosus. Arthritis & Rheumatism 62:6, pages 1702-1711.
Crossref
Crossref
Hyoun-Ah Kim, Ja-Young Jeon, Jeong-Moon Yoon & Chang-Hee Suh. (2010) Beta2-Microglobulin Can Be a Disease Activity Marker in Systemic Lupus Erythematosus. The American Journal of the Medical Sciences 339:4, pages 337-340.
Crossref
Crossref
. 2010. Robbins and Cotran Pathologic Basis of Disease. Robbins and Cotran Pathologic Basis of Disease
183
257
.
Emily Walters, Virginia Rider, Nabih I. Abdou, Cindy Greenwell, Stan Svojanovsky, Peter Smith & Bruce F. Kimler. (2009) Estradiol targets T cell signaling pathways in human systemic lupus. Clinical Immunology 133:3, pages 428-436.
Crossref
Crossref
Andras Perl. (2009) Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Current Opinion in Rheumatology 21:5, pages 443-447.
Crossref
Crossref
Andras Perl, David R Fernandez, Tiffany Telarico, Edward Doherty, Lisa Francis & Paul E Phillips. (2009) T-cell and B-cell signaling biomarkers and treatment targets in lupus. Current Opinion in Rheumatology 21:5, pages 454-464.
Crossref
Crossref
Chau-Ching Liu & Joseph M. Ahearn. (2009) The search for lupus biomarkers. Best Practice & Research Clinical Rheumatology 23:4, pages 507-523.
Crossref
Crossref
Clive BowmanOlivier Delrieu. (2009) Immunogenetics of drug-induced skin blistering disorders. Part II: Synthesis. Pharmacogenomics 10:5, pages 779-816.
Crossref
Crossref
Clive BowmanOlivier Delrieu. (2009) Immunogenetics of drug-induced skin blistering disorders. Part I: Perspective. Pharmacogenomics 10:4, pages 601-621.
Crossref
Crossref
David R. Fernandez, Tiffany Telarico, Eduardo Bonilla, Qing Li, Sanjay Banerjee, Frank A. Middleton, Paul E. Phillips, Mary K. Crow, Stefanie Oess, Werner Muller-Esterl & Andras Perl. (2009) Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation. The Journal of Immunology 182:4, pages 2063-2073.
Crossref
Crossref
R. H. B. Benedict, J. L. Shucard, R. Zivadinov & D. W. Shucard. (2008) Neuropsychological Impairment in Systemic Lupus Erythematosus: A Comparison with Multiple Sclerosis. Neuropsychology Review 18:2, pages 149-166.
Crossref
Crossref
Jeffrey C. Edberg, Jianming Wu, Carl D. Langefeld, Elizabeth E. Brown, Miranda C. Marion, Gerald McGwinJrJr, Michelle Petri, Rosalind Ramsey-Goldman, John D. Reveille, Summer G. Frank, Kenneth M. Kaufman, John B. Harley, Graciela S. Alarcón & Robert P. Kimberly. (2008) Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Human Molecular Genetics 17:8, pages 1147-1155.
Crossref
Crossref
Daniel J Wallace. (2007) Future management of systemic lupus erythematosus. Future Rheumatology 2:3, pages 229-231.
Crossref
Crossref